Membrane Steroid Receptor-Mediated Action of Soy Isoflavones: Tip of the Iceberg

Journal of Membrane Biology

Volumn 248, Issue 1, 2015, Pages 1-6

  Ajdžanović, Vladimir ^a   Medigović, Ivana ^a   Živanović, Jasmina ^a   Mojić, Marija ^a   Milošević, Verica ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cell membrane; Membrane steroid receptor; Soy isoflavones

Indexed keywords

ANDROGEN RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; DAIDZEIN; GENISTEIN; MEMBRANE LIPID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STEROID RECEPTOR; ISOFLAVONE DERIVATIVE; MEMBRANE PROTEIN; PROTEIN BINDING;

CATECHOLAMINE SYNTHESIS; CELL MEMBRANE; CELL SURFACE; DEPRESSION; DOWN REGULATION; EPIGENETICS; ICEBERG; IMMOBILIZATION; IN VITRO STUDY; LNCAP CELL LINE; MEMBRANE; MEMBRANE FLUIDITY; REVIEW; ANIMAL; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; SOYBEAN;

ANIMALS; GENISTEIN; HUMANS; ISOFLAVONES; MEMBRANE PROTEINS; PROTEIN BINDING; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; SOYBEANS;

EID: 84922006763     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-014-9745-x     Document Type: Review

References (67)

1. Adlanmerini M, Solinhac R, Abot A, Fabre A, Raymond-Letron I, Guihot AL, Boudou F, Sautier L, Vessières E, Kim SH, Lière P, Fontaine C, Krust A, Chambon P, Katzenellenbogen JA, Gourdy P, Shaul PW, Henrion D, Arnal JF, Lenfant F (2014) Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci USA 111:E283–E290
2. Ajdžanović V, Spasojević I, Filipović B, Šošić-Jurjević B, Sekulić M, Milošević V (2010) Effects of genistein and daidzein on erythrocyte membrane fluidity: an electron paramagnetic resonance study. Can J Physiol Pharmacol 88:497–500
3. Ajdžanović V, Spasojević I, Šošić-Jurjević B, Filipović B, Trifunović S, Sekulić M, Milošević V (2011) The negative effect of soy extract on erythrocyte membrane fluidity: an electron paramagnetic resonance study. J Membr Biol 239:131–135
4. Ajdžanović V, Milošević V, Spasojević I (2012) Glucocorticoid excess and disturbed hemodynamics in advanced age: the extent to which soy isoflavones may be beneficial. Gen Physiol Biophys 31:367–374
5. Ajdžanović V, Mojić M, Maksimović-Ivanić D, Bulatović M, Mijatović S, Milošević V, Spasojević I (2013) Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones. J Membr Biol 246:307–314
6. Ajdžanović V, Medigović I, Pantelić J, Milošević V (2014) Soy isoflavones and cellular mechanics. J Bioenerg Biomembr 46:99–107
7. Asnacios A, Hamant O (2012) The mechanics behind cell polarity. Trends Cell Biol 22:584–591
8. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
9. Beck V, Rohr U, Jungbauer A (2005) Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? J Steroid Biochem Mol Biol 94:499–518
10. Benten WP, Lieberherr M, Giese G, Wrehlke C, Stamm O, Sekeris CE, Mossmann H, Wunderlich F (1999) Functional testosterone receptors in plasma membranes of T cells. FASEB J 13:123–133
11. Blake C, Fabick KM, Setchell KDR, Lund TD, Lephart ED (2011) Neuromodulation by soy diets or equol: Anti-depressive & anti-obesity-like influences, age- & hormone-dependent effects. BMC Neurosci 12:28
12. Cinar B, Mukhopadhyay NK, Meng G, Freeman MR (2007) Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains. J Biol Chem 282:29584–29593
13. El Touny LH, Banerjee PP (2007) Akt GSK-3 pathway as a target in genistein induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. Carcinogenesis 28:1710–1717
14. Esquela-Kercher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6:259–269
15. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M (2000) Multiple actions of steroid hormones—a focus on rapid, nongenomic effects. Pharmacol Rev 52:513–556
16. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P (2007) Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148:3236–3245
17. Foradori CD, Weiser MJ, Handa RJ (2008) Non-genomic actions of androgens. Front Neuroendocrinol 29:169–181
18. Gatson JW, Kaur P, Singh M (2006) Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 147:2028–2034
19. Giguère V, Yang N, Sequi P, Evans RM (1988) Identification of a new class of steroid hormone receptors. Nature 331:91–94
20. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150–1154
21. Hammes SR, Levin ER (2011) Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology 152:4489–4495
22. Heinlein CA, Chang C (2002) The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16:2181–2187
23. Heinlein CA, Chang C (2004) Androgen receptor in prostate cancer. Endocr Rev 25:276–308
24. Jacob J, Sebastian KS, Devassy S, Priyadarsini L, Farook MF, Shameem A, Mathew D, Sreeja S, Thampan RV (2006) Membrane estrogen receptors: genomic actions and post transcriptional regulation. Mol Cell Endocrinol 246:34–41
25. Kalaiselvan V, Kalaivani M, Vijayakumar A, Sureshkumar K, Venkateskumar K (2010) Current knowledge and future direction of research on soy isoflavones as a therapeutic agents. Pharmacogn Rev 4:111–117
26. Kallergi G, Agelaki S, Markomanolaki H, Georgoulias V, Stournaras C (2007) Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells. Cell Physiol Biochem 20:977–986
27. Kampa M, Papakonstanti EA, Hatzoglou A, Stathopoulos EN, Stournaras C, Castanas E (2002) The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors, which increase PSA secretion and modify actin cytoskeleton. FASEB J 16:1429–1431
28. Kampa M, Nifli AP, Charalampopoulos I, Alexaki VI, Theodoropoulos PA, Stathopoulos EN, Gravanis A, Castanas E (2005) Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis. Exp Cell Res 307:41–51
29. Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, Stathopoulos EN, Hatzoglou A, Stournaras C, Gravanis A, Castanas E (2006) Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol Cancer Ther 5:1342–1351
30. Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863–870
31. Kumar R, Zakharov MN, Khan SH, Miki R, Jang H, Toraldo G, Singh R, Bhasin S, Jasuja R (2011) The dynamic structure of the estrogen receptor. J Amino Acids 2011:812540
32. Levin ER (2011) Minireview: extranuclear steroid receptors: roles in modulation of cell functions. Mol Endocrinol 25:377–384
33. Liao RS, Ma S, Miao L, Li R, Yin Y, Raj GV (2013) Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation. Transl Androl Urol 2:187–196
34. Liu M, Yanagihara N, Toyohira Y, Tsutsui M, Ueno S, Shinohara Y (2007) Dual effects of daidzein, a soy isoflavone, on catecholamine synthesis and secretion in cultured bovine adrenal medullary cells. Endocrinology 148:5348–5354
35. Liu S, Le May C, Wong WP, Ward RD, Clegg DJ, Marcelli M, Korach KS, Mauvais-Jarvis F (2009) Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 58:2292–2302
36. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP (2001) Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276:13442–13451
37. Lyng FM, Jones GR, Rommerts FF (2000) Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations. Biol Reprod 63:736–747
38. Madeo A, Maggiolini M (2010) Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res 70:6036–6046
39. Mahmoud AM, Yang W, Bosland MC (2014) Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol 140:116–132
40. Marino M, Pellegrini M, La Rosa P, Acconcia F (2012) Susceptibility of estrogen receptor rapid responses to xenoestrogens: physiological outcomes. Steroids 77:910–917
41. McEwen B (2002) Estrogen actions throughout the brain. Recent Prog Horm Res 57:357–384
42. Milenkovic D, Deval C, Gouranton E, Landrier JF, Scalbert A, Morand C, Mazur A (2012) Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLoS ONE 7:e29837
43. Milenkovic D, Jude B, Morand C (2013) miRNA as molecular target of polyphenols underlying their biological effects. Free Radic Biol Med 64:40–51
44. Miska EA (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15:563–568
45. Moriarty K, Kim KH, Bender JR (2006) Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 147:5557–5563
46. Nadal A, Rovira JM, Laribi O, Leon-quinto T, Andreu E, Ripoll C, Soria B (1998) Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor. FASEB J 12:1341–1348
47. Norman AW, Mizwicki MT, Norman DP (2004) Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3:27–41
48. Oh HY, Leem J, Yoon SJ, Yoon S, Hong SJ (2010) Lipid raft cholesterol and genistein inhibit the cell viability of prostate cancer cells via the partial contribution of EGFR-Akt/p70S6k pathway and down-regulation of androgen receptor. Biochem Biophys Res Commun 393:319–324
49. Papadopoulou N, Charalampopoulos I, Anagnostopoulou V, Konstantinidis G, Föller M, Gravanis A, Alevizopoulos K, Lang F, Stournaras C (2008) Membrane androgen receptor activation triggers down-regulation of PI-3K/Akt/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells. Mol Cancer 7:88
50. Papakonstanti EA, Kampa M, Castanas E, Stournaras C (2003) A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Mol Endocrinol 17:870–881
51. Peterziel H, Mink S, Schonert A, Becker M, Klocker H, Cato AC (1999) Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 18:6322–6329
52. Pralle A, Keller P, Florin EL, Simons K, Hörber JK (2000) Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J Cell Biol 148:997–1008
53. Rahman F, Christian HC (2007) Non-classical actions of testosterone: an update. Trends Endocrinol Metab 18:371–378
54. Roepke TA, Ronnekleiv OK, Kelly MJ (2011) Physiological consequences of membrane-initiated estrogen signaling in brain. Front Biosci (Landmark Ed) 16:1560–1573
55. Setchell KDR (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68:1333S–1346S
56. Soltysik K, Czekaj P (2013) Membrane estrogen receptors—is it an alternative way of estrogen action? J Physiol Pharmacol 64:129–142
57. Sud N, Wiseman DA, Black SM (2010) Caveolin 1 is required for the activation of endothelial nitric oxide synthase in response to 17beta-estradiol. Mol Endocrinol 24:1637–1649
58. Sun YH, Gao X, Tang YJ, Xu CL, Wang LH (2006) Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells. J Androl 27:671–678
59. Tarahovsky YS, Kim YA, Yagolnik EA, Muzafarov EN (2014) Flavonoid-membrane interactions: involvement of flavonoid-metal complexes in raft signaling. BBA Biomembr 1838:1235–1246
60. Watson CS, Gametchu B (1999) Membrane-initiated steroid actions and the proteins that mediate them. Proc Soc Exp Biol Med 220:9–19
61. Watson CS, Alyea RA, Jeng YJ, Kochukov MY (2007) Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues. Mol Cell Endocrinol 274:1–7
62. Westfall TC, Westfall DP (2005) Adrenergic agonists and antagonists. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman, Gilman the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York, pp 237–295
63. Xie H, Sun M, Liao XB, Yuan LQ, Sheng ZF, Meng JC, Wang D, Yu ZY, Zhang LY, Zhou HD, Luo XH, Li H, Wu XP, Wei QY, Tang SY, Wang ZY, Liao EY (2011) Estrogen receptor α36 mediates a bone-sparing effect of 17β-estradiol in postmenopausal women. J Bone Miner Res 26:156–168
64. Yanagihara N, Liu M, Toyohira Y, Tsutsui M, Ueno S, Shinohara Y, Takahashi K, Tanaka K (2006) Stimulation of catecholamine synthesis through unique estrogen receptors in the bovine adrenomedullary plasma membrane by 17β-estradiol. Biochem Biophys Res Commun 339:548–553
65. Yanagihara N, Toyohira Y, Shinohara Y (2008) Insights into the pharmacological potential of estrogens and phytoestrogens on catecholamine signaling. Ann NY Acad Sci 1129:96–104
66. Yu J, Akishita M, Eto M, Koizumi H, Hashimoto R, Ogawa S, Tanaka K, Ouchi Y, Okabe T (2012) Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthase. Biochem Biophys Res Commun 424:538–543
67. Zicha J, Kunes J, Devynck MA (1999) Abnormalities of membrane function and lipid metabolism in hypertension. Am J Hypertens 12:315–331